# Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy

> **NCT07476404** · — · COMPLETED · sponsor: **Chiang Mai University** · enrollment: 300 (actual)

## Conditions studied

- Meningioma of Brain
- Meningioma Surgery

## Interventions

- **OTHER:** exposure to Hydroxyethyl Starch (HES) Voluven® or Volulyte® 130/0.4

## Key facts

- **NCT ID:** NCT07476404
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-01
- **Primary completion:** 2026-02-14
- **Final completion:** 2026-03-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07476404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07476404, "Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07476404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
